Tara I Chang1, Grace H Tabada, Jingrong Yang, Thida C Tan, Alan S Go. 1. aStanford University School of Medicine, StanfordbDivision of Research, Kaiser Permanente Northern California, OaklandcDepartments of Epidemiology, Biostatistics and Medicine, University of California, San Francisco, California, USA.
Abstract
OBJECTIVES: Visit-to-visit variability of blood pressure (VVV of BP) is an important independent risk factor for premature death and cardiovascular events, but relatively little is known about this phenomenon in patients with chronic kidney disease (CKD) not yet on dialysis. METHODS: We conducted a retrospective study in a community-based cohort of 114 900 adults with CKD stages 3-4 (estimated glomerular filtration rate 15-59 ml/min per 1.73 m). We hypothesized that VVV of BP would be independently associated with higher risks of death, incident treated end-stage renal disease, and cardiovascular events. We defined systolic VVV of BP using three metrics: coefficient of variation, standard deviation of the mean SBP, and average real variability. RESULTS: The highest versus the lowest quintile of the coefficient of variation was associated with higher adjusted rates of death (hazard ratio 1.22; 95% confidence interval 1.11-1.34) and hemorrhagic stroke (hazard ratio 1.91; confidence interval 1.36-2.68). VVV of BP was inconsistently associated with heart failure, and was not significantly associated with acute coronary syndrome and ischemic stroke. Results were similar when using the other two metrics of VVV of BP. VVV of BP had inconsistent associations with end-stage renal disease, perhaps because of the relatively low incidences of this outcome. CONCLUSION: Higher VVV of BP is independently associated with higher rates of death and hemorrhagic stroke in patients with moderate to advanced CKD not yet on dialysis.
OBJECTIVES:Visit-to-visit variability of blood pressure (VVV of BP) is an important independent risk factor for premature death and cardiovascular events, but relatively little is known about this phenomenon in patients with chronic kidney disease (CKD) not yet on dialysis. METHODS: We conducted a retrospective study in a community-based cohort of 114 900 adults with CKD stages 3-4 (estimated glomerular filtration rate 15-59 ml/min per 1.73 m). We hypothesized that VVV of BP would be independently associated with higher risks of death, incident treated end-stage renal disease, and cardiovascular events. We defined systolic VVV of BP using three metrics: coefficient of variation, standard deviation of the mean SBP, and average real variability. RESULTS: The highest versus the lowest quintile of the coefficient of variation was associated with higher adjusted rates of death (hazard ratio 1.22; 95% confidence interval 1.11-1.34) and hemorrhagic stroke (hazard ratio 1.91; confidence interval 1.36-2.68). VVV of BP was inconsistently associated with heart failure, and was not significantly associated with acute coronary syndrome and ischemic stroke. Results were similar when using the other two metrics of VVV of BP. VVV of BP had inconsistent associations with end-stage renal disease, perhaps because of the relatively low incidences of this outcome. CONCLUSION: Higher VVV of BP is independently associated with higher rates of death and hemorrhagic stroke in patients with moderate to advanced CKD not yet on dialysis.
Authors: Alan S Go; Jingrong Yang; Lynn M Ackerson; Krista Lepper; Sean Robbins; Barry M Massie; Michael G Shlipak Journal: Circulation Date: 2006-06-05 Impact factor: 29.690
Authors: Luis Mena; Salvador Pintos; Nestor V Queipo; José A Aizpúrua; Gladys Maestre; Tulio Sulbarán Journal: J Hypertens Date: 2005-03 Impact factor: 4.844
Authors: Daichi Shimbo; Jonathan D Newman; Aaron K Aragaki; Michael J LaMonte; Anthony A Bavry; Matthew Allison; JoAnn E Manson; Sylvia Wassertheil-Smoller Journal: Hypertension Date: 2012-07-02 Impact factor: 10.190
Authors: Astrid M Suchy-Dicey; Ying Zhang; Sterling McPherson; Katherine R Tuttle; Barbara Howard; Jason Umans; Dedra S Buchwald Journal: Kidney360 Date: 2021-01-28
Authors: L Parker Gregg; S Susan Hedayati; Hui Yang; Peter N Van Buren; Subhash Banerjee; Sankar D Navaneethan; Salim S Virani; Wolfgang C Winkelmayer; Carlos A Alvarez Journal: Hypertension Date: 2021-01-11 Impact factor: 10.190